To investigate this possibility, we utilized a CLL cell line MEC-1, and using the CRISPR/Cas9 technology, we prepared individual cell clones (Supplementary Methods) with mutated miR-155 recognizing the MARCKS mRNA. The gene discussed is MARCKS; the disease is B-cell chronic lymphocytic leukemia.